ToyA, a positive pathway-specific regulator for toyocamycin biosynthesis in Streptomyces diastatochromogenes 1628
The nucleoside antibiotic toyocamycin (TM), which was produced by Streptomyces diastatochromogenes 1628, was found to be highly efficient against a broad range of plant pathogenic fungi. Despite its importance, little is known about the regulation TM biosynthesis. In this study, toyA, located in the TM biosynthetic gene cluster, was identified as a regulatory gene encoding a large ATP-binding regulator of the LuxR family (LAL-family). The role of toyA in TM biosynthesis in S. diastatochromogenes 1628 was investigated by gene deletion, complementation, and over-expression. Gene disruption of toyA resulted in almost loss of TM production. TM production in complemented strain was restored to the level comparable to that in the wild-type strain S. diastatochromogenes 1628. Over-expression of toyA separately controlled by promoter SPL57, SPL21, and permE* in wild-type strain S. diastatochromogenes 1628 led to a 2-fold, 1-fold, and 80% increase in TM production compared with wild-type strain S. diastatochromogenes 1628, respectively. Quantitative RT-PCR analysis revealed that the transcriptional level of toy structural genes was downregulated in the ΔtoyA mutant but restored in complemented strain and further upregulated in the toyA over-expression strain. The detection results from GFP reporter system in Escherichia coli and GUS reporter system and GUS activities in S. albus J1074 and S. diastatochromogenes 1628 showed that ToyA activated the expression of toyB and toyE operon directly and activated the expression of other toy structural genes indirectly. These results indicate that ToyA is essential for TM biosynthesis controlling the expression of structural genes.
KeywordsToyocamycin Streptomyces diastatochromogenes ToyA gene Pathway-specific regulator Regulatory mechanism
This work was supported by excellent youth fund of Zhejiang province, China (LR17C140002) and National Natural Science Foundation of China (31772213, 31401792).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with human participants or animals performed by any of the authors.
- Gibson DG, Benders GA, Axelrod KC, Zaveri J, Algire MA, Moodie M, Montague MG, Venter JC, Smith HO, Hutchison CA (2008) One-step assembly in yeast of 25 overlapping DNA fragments to form a complete synthetic Mycoplasma genitalium genome. Proc Natl Acad Sci U S A 105(51):20404–20409PubMedPubMedCentralGoogle Scholar
- Guo J, Zhao J, Li L, Chen Z, Wen Y, Li J (2010) The pathway-specific regulator AveR from Streptomyces avermitilis positively regulates avermectin production while it negatively affects oligomycin biosynthesis. Mol Gen Genomics 283(2):123–133Google Scholar
- Huang Y, Yang D, Pan G, Tang GL, Shen B (2016) Characterization of LnmO as a pathway-specific Crp/Fnr-type positive regulator for leinamycin biosynthesis in Streptomyces atroolivaceus and its application for titer improvement. Appl Microbiol Biotechnol 100(24):10555–10562PubMedPubMedCentralGoogle Scholar
- Kallifidas D, Jiang G, Ding Y, Luesch H (2018) Rational engineering of Streptomyces albus J1074 for the overexpression of secondary metabolite gene clusters. Microb Cell Factories 17(1):25Google Scholar
- Kieser T, Bibb MJ, Buttner MJ, Chater KF, Hopwood DA (2000) Practical Streptomyces genetics. John Innes Foundation, NorwichGoogle Scholar
- Ma Z, Luo S, Xu X, Bechthold A, Yu X (2016) Characterization of representative rpoB, gene mutations leading to a significant change in toyocamycin production of Streptomyces diastatochromogenes 1628. J Ind Microbiol Biot 43(4):463–471Google Scholar
- Martínez-Burgo Y, Álvarez-Álvarez R, Rodríguez-García A, Liras P (2015) The pathway-specific regulator clar of Streptomyces clavuligerus has a global effect on the expression of genes for secondary metabolism and differentiation. Appl Environ Microb 81(19):6637–6648Google Scholar
- Rodríguez H, Rico S, Díaz M, Santamaría RI (2013) Two-component systems in Streptomyces: key regulators of antibiotic complex pathways. Microb Cell Factories 12:127Google Scholar
- Sambrook J, Russel DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory, New YorkGoogle Scholar
- Sekurova ON, Brautaset T, Sletta H, Borgos SE, Jakobsen MØM, Ellingsen TE, Strøm AR, Valla S, Zotchev SB (2004) In vivo analysis of the regulatory genes in the nystatin biosynthetic gene cluster of Streptomyces noursei ATCC 11455 reveals their differential control over antibiotic biosynthesis. J Bacteriol 186(5):1345–1354PubMedPubMedCentralGoogle Scholar
- Tao L, Ma Z, Xu X, Bechthold A, Bian Y, Shentu X, Yu X (2016) Engineering Streptomyces diastatochromogenes 1628 to increase the production of toyocamycin. Eng Life Sci 15(8):779–787Google Scholar
- Wan X, Marsafari M, Xu P (2019) Engineering metabolite-responsive transcriptional factors to sense small molecules in eukaryotes: current state and perspectives. Microb Cell Factories 18:61Google Scholar
- Yin S, Wang W, Wang X, Zhu Y, Jia X, Li S (2015) Identification of a cluster-situated activator of oxytetracycline biosynthesis and manipulation of its expression for improved oxytetracycline production in Streptomyces rimosus. Microb Cell Factories 14(1):46Google Scholar
- Zhang Y, He H, Liu H, Wang H, Wang X, Xiang W (2016) Characterization of a pathway-specific activator of milbemycin biosynthesis and improved milbemycin production by its overexpression in Streptomyces bingchenggensis. Microb Cell Factories 15(1):152Google Scholar